CN1493310A - Medicine for treating chronic colonitis - Google Patents
Medicine for treating chronic colonitis Download PDFInfo
- Publication number
- CN1493310A CN1493310A CNA021325251A CN02132525A CN1493310A CN 1493310 A CN1493310 A CN 1493310A CN A021325251 A CNA021325251 A CN A021325251A CN 02132525 A CN02132525 A CN 02132525A CN 1493310 A CN1493310 A CN 1493310A
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- radix
- gram
- poria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of powder for treating chronic colitis and ulcerative colitis is prepared from 8 Chinese-medicinal materials including astragalus root, liquorice root, white peony root, cuttlefish bone, etc. Its advantages are high curative effect, no recurrence, no toxic by-effect and low cost.
Description
Technical field:
The invention belongs to the Chinese powder medicine of treatment chronic colitis and ulcerative colitis.
Background technology:
Chronic colitis, ulcerative colitis, Anaphylaxis enteritis, irritable bowel syndrome and diarrhoea are common clinical, frequently-occurring disease, this disease state of an illness complexity, and medical circle is not clear fully as yet to its pathogenic factor at present.Clinical commonly used drug, as: Spleen Invigorating and Intestine Tonifying Pill, GUBEN YICHANG PIAN etc., curative effect is unsatisfactory, and the relapse rate height, and late result is poor.Therefore, lack effective Therapeutic Method and medicine, classified as one of 14 kinds of refractory diseases by World Health Organization (WHO).
Summary of the invention:
The present invention solves the problem that curative effect of medication is undesirable, relapse rate is high of treatment chronic colitis at present, provides a kind of curative effect reliable, and indication is wide, has no side effect, cheap Chinese medicine.
The present invention adopts following technical scheme: component of the present invention is: Radix Astragali 50-100 gram, Radix Glycyrrhizae 20-30 gram, Radix Paeoniae Alba 20-30 gram, blue or green shellfish 10-20 gram, Bulbus Fritillariae Thunbergii 10-20 gram, Endoconcha Sepiae 20-30 gram, Poria 20-30 gram, Rhizoma Corydalis (processed) 20-30 gram.
The screening of above-mentioned medicine is clean, pulverizes, through 100 mesh sieve mix homogeneously, and packing packages spare.
This medicine is based on motherland's theory of medicine, is foundation with modern science to the current research of Chinese medicine, its reasonable recipe, and prescription is unique.Reuse Radix Astragali holder skin ulcer granulation promoting in this medicine, strengthening the body resistance; The Radix Paeoniae Alba, Rhizoma Corydalis (processed) nourishing blood to suppress the hyperactive liver regulating QI to relieve pain; Radix Glycyrrhizae, Poria invigorating spleen to remove dampness; Skin ulcer is held back in two shellfishes, Endoconcha Sepiae lung heat clearing; Full medicine does not have antiinflammatory antidiarrheal simply, but shows the merit of antiinflammatory stopping leak.
Beneficial effect of the present invention:
One, curative effect is reliable, the cure rate height:
This medicine my institute use ten surplus year, during through revising repeatedly, clinical verification is now finalized the design.There are 3000 many cases patients to use this medicine over 10 years, according to clinical statistics effective percentage 98%, cure rate 85%.Based on oral powder, be aided with the external coloclysis individually, one time 5 gram, 2-3 time on the one, one month is a course of treatment, generally takes 2-3 the course of treatment, special circumstances are decided on the state of an illness.
Physical data is added up 3000 examples, male 1650 examples, and women 1350 examples, the course of disease is the longest 38 years, and the shortest is 6 months, does not classify primary disease below half a year as, the oldest person 79 years old, reckling 18 years old.
By traditional Chinese medical science typing excess syndrome 588 examples, deficiency syndrome 2412 examples.
By the doctor trained in Western medicine typing, chronic colitis 2115 examples, ulcerative colitis 605 examples, irritated colitis 38 examples, irritable bowel syndrome 101 examples, chronic diarrhea 141 examples.
The Radix Astragali, Radix Glycyrrhizae, blue or green shellfish, Bulbus Fritillariae Thunbergii, Endoconcha Sepiae, Poria, Rhizoma Corydalis (processed), medicine-feeding screening is clean, pulverizes, through 100 mesh sieves, and it is standby to mix packing.
This medicine is a powder, each oral 5 grams, 2-3 time on the one, 30 minutes after meal warm water delivery services; One month is a course of treatment, general two to three courses of treatment or decide on the state of an illness.
The judgement of criterion of therapeutical effect:
Recent clinical cure, the clinical symptoms complete obiteration, the check of electronics large intestine mirror, the congested swelling of intestinal mucosa is disappeared, and the blood vessel lines is clear, and mucomembranous color is normal, and drug withdrawal does not have uncomfortable reaction more than 30 days.
Produce effects: clinical symptoms disappears substantially, the check of electronics large intestine mirror, and endo enteritis obviously alleviates, and color and luster is near normal.
Take a turn for the better: clinical cardinal symptom alleviates, and also has the sense of discomfort, the electronics total colonoscopy, and the part inflammation disappears, and is whole than taking a turn for the better to some extent before the treatment.
Invalid: clinical symptoms does not have obvious change, and the check of electronics large intestine mirror is with the last sample of treatment.
Therapeutic outcome:
This statistics is organized 3000 examples and is all met diagnostic criteria, and clinical cure 2568 examples account for 85% of sum in the recent period, produce effects 216 examples, and obvious effective rate accounts for 7.1%, and 158 examples that take a turn for the better account for sum 5%, invalid 68 examples, inefficiency accounts for 2.4%.
Two, strengthening the body resistance has no side effect:
The used Chinese medicine of this medicine is Chinese medicine, has no side effect; Reuse Radix Astragali strengthening the body resistance in this medicine, the QI invigorating granulation promoting, Poria, Radix Glycyrrhizae invigorating spleen to remove dampness can be removed symptoms such as stomachache, diarrhoea, bloody purulent stool after the patient takes medicine effectively, and improve immunocompetence, improve General Symptoms, stable disease, more the back is difficult for recurrence.
Three, the property of medicine is gentle, and indication is wide:
This medicine often course of disease is very long, state of an illness complexity, and deficient and excessive syndromes appearing together, cold and heat are staggered, for clinician's medication brings very big difficulty.Make a general survey of this medicine, cold not hot not dry, the property of medicine is comparatively gentle; Though used cold and cool blue or green shellfish, there is the Radix Astragali that is several times as much as it to restrict the cold and cool of blue or green shellfish, the property that the dry Rhizoma Corydalis (processed) of gas is held back with the acid of the Radix Paeoniae Alba is received it, makes all medicine property of medicine in this medicine gentle; Its subject range is extensive, no matter be asthenic cold type or excess-heat type, and damp-heat type or damp abundance due to splenic asthenia type, this medicine can both be suitable for, and is that multiple disease type one side transfers.
Four, make simply, cheap:
This medicine is a Chinese medicine powder, and its processing technology is simple, and it is comparatively convenient to take, and is easy to preserve, and is cheap, and tens yuan of courses of treatment, for the chronic, this is a very big advantage.
The specific embodiment:
Embodiment 1:
The Radix Astragali 50 grams, Radix Glycyrrhizae 20 grams, the Radix Paeoniae Alba 20 grams, blue or green shellfish 10 grams, Bulbus Fritillariae Thunbergii 10 grams, Endoconcha Sepiae 20 grams, Poria 20 grams, Rhizoma Corydalis (processed) 20 grams.
Embodiment 2:
The Radix Astragali 60 grams, Radix Glycyrrhizae 22 grams, the Radix Paeoniae Alba 22 grams, blue or green shellfish 12 grams, Bulbus Fritillariae Thunbergii 12 grams, Endoconcha Sepiae 22 grams, Poria 22 grams, Rhizoma Corydalis (processed) 22 grams.
Embodiment 3:
The Radix Astragali 80 grams, Radix Glycyrrhizae 25 grams, the Radix Paeoniae Alba 25 grams, blue or green shellfish 15 grams, Bulbus Fritillariae Thunbergii 15 grams, Endoconcha Sepiae 25 grams, Poria 25 grams, Rhizoma Corydalis (processed) 25 grams.
Embodiment 4:
The Radix Astragali 100 grams, Radix Glycyrrhizae 30 grams, the Radix Paeoniae Alba 30 grams, blue or green shellfish 20 grams, Bulbus Fritillariae Thunbergii 20 grams, Endoconcha Sepiae 30 grams, Poria 30 grams, Rhizoma Corydalis (processed) 30 grams.
Embodiment 5:
The Radix Astragali 95 grams, Radix Glycyrrhizae 20 grams, the Radix Paeoniae Alba 20 grams, blue or green shellfish 18 grams, Bulbus Fritillariae Thunbergii 10 grams, Endoconcha Sepiae 30 grams, Poria 25 grams, Rhizoma Corydalis (processed) 25 grams.
Claims (6)
1, a kind of component for the treatment of the medicine of chronic colitis is: Radix Astragali 50-100 gram, Radix Glycyrrhizae 20-30 gram, Radix Paeoniae Alba 20-30 gram, blue or green shellfish 10-20 gram, Bulbus Fritillariae Thunbergii 10-20 gram, Endoconcha Sepiae 20-30 gram, Poria 20-30 gram, Rhizoma Corydalis (processed) 20-30 gram.
2, a kind of medicine for the treatment of chronic colitis according to claim 1 is characterized in that the Radix Astragali 50 grams, Radix Glycyrrhizae 20 grams, the Radix Paeoniae Alba 20 grams, blue or green shellfish 10 grams, Bulbus Fritillariae Thunbergii 10 grams, Endoconcha Sepiae 20 grams, Poria 20 grams, Rhizoma Corydalis (processed) 20 grams.
3, a kind of medicine for the treatment of chronic colitis according to claim 1 is characterized in that the Radix Astragali 60 grams, Radix Glycyrrhizae 22 grams, the Radix Paeoniae Alba 22 grams, blue or green shellfish 12 grams, Bulbus Fritillariae Thunbergii 12 grams, Endoconcha Sepiae 22 grams, Poria 22 grams, Rhizoma Corydalis (processed) 22 grams.
4, a kind of medicine for the treatment of chronic colitis according to claim 1 is characterized in that the Radix Astragali 80 grams, Radix Glycyrrhizae 25 grams, the Radix Paeoniae Alba 25 grams, blue or green shellfish 15 grams, Bulbus Fritillariae Thunbergii 15 grams, Endoconcha Sepiae 25 grams, Poria 25 grams, Rhizoma Corydalis (processed) 25 grams.
5, a kind of medicine for the treatment of chronic colitis according to claim 1 is characterized in that the Radix Astragali 100 grams, Radix Glycyrrhizae 30 grams, the Radix Paeoniae Alba 30 grams, blue or green shellfish 20 grams, Bulbus Fritillariae Thunbergii 20 grams, Endoconcha Sepiae 30 grams, Poria 30 grams, Rhizoma Corydalis (processed) 30 grams.
6, a kind of medicine for the treatment of chronic colitis according to claim 1 is characterized in that the Radix Astragali 95 grams, Radix Glycyrrhizae 20 grams, the Radix Paeoniae Alba 20 grams, blue or green shellfish 18 grams, Bulbus Fritillariae Thunbergii 10 grams, Endoconcha Sepiae 30 grams, Poria 25 grams, Rhizoma Corydalis (processed) 25 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021325251A CN1273172C (en) | 2002-07-04 | 2002-07-04 | Medicine for treating chronic colonitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021325251A CN1273172C (en) | 2002-07-04 | 2002-07-04 | Medicine for treating chronic colonitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1493310A true CN1493310A (en) | 2004-05-05 |
| CN1273172C CN1273172C (en) | 2006-09-06 |
Family
ID=34231264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021325251A Expired - Fee Related CN1273172C (en) | 2002-07-04 | 2002-07-04 | Medicine for treating chronic colonitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1273172C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1294819C (en) * | 2004-10-09 | 2007-01-17 | 宋述孝 | Dehydrating and freshness preserving method for lichee and longan and product produced by said method |
| CN102895448A (en) * | 2012-10-25 | 2013-01-30 | 杨丽梅 | Chinese medicine for treating chronic colitis |
-
2002
- 2002-07-04 CN CNB021325251A patent/CN1273172C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1294819C (en) * | 2004-10-09 | 2007-01-17 | 宋述孝 | Dehydrating and freshness preserving method for lichee and longan and product produced by said method |
| CN102895448A (en) * | 2012-10-25 | 2013-01-30 | 杨丽梅 | Chinese medicine for treating chronic colitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1273172C (en) | 2006-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100336546C (en) | Chinese medicinal preparation for treating gastroenteric disease | |
| CN1973683A (en) | Health food and its production process | |
| CN1476849A (en) | Medicine composition for promoting blood circulation and removing stasis | |
| CN1301737C (en) | Chinese medicinal preparation for treating diabetes and its preparation method | |
| CN1895573A (en) | Pharmaceutical composition for treating oral ulcer and preparation method and application thereof | |
| CN1046421C (en) | Drug for curing pulmonary tuberculosis | |
| CN103182059B (en) | Traditional Chinese medicine composition for treating chronic gastritis, and application thereof | |
| CN1294015A (en) | Medicine for treating thyroid enlargement and thyroidism | |
| CN1493310A (en) | Medicine for treating chronic colonitis | |
| CN101693084B (en) | Medical composition for treating epigastric pain yin deficiency syndrome and preparation method thereof | |
| CN1324656A (en) | Chinese medicine prepn. with immunity strengthening effect | |
| CN1903347A (en) | Medicine composition for treating alimentary canal diseases, prepn. method and application thereof | |
| CN1087946C (en) | Medicine for curing diabetes | |
| CN1265818C (en) | Leech capsule | |
| CN1285367C (en) | Medicinal preparation for treating diabetes and its preparation method | |
| CN111228367A (en) | Traditional Chinese medicine external lotion for treating infantile anaphylactoid purpura and preparation method thereof | |
| CN1387891A (en) | Chinese medicine prepn for treating deficiency of spleen and stomach Yang type atrophic gastritis | |
| CN1903326A (en) | Medicine composition for treating digestive exulceratio | |
| CN1076622C (en) | Chinese medicine for curing nephritis | |
| CN1159054C (en) | Tongfuzhixie preparation | |
| CN116763880B (en) | Traditional Chinese medicine composition and preparation for treating functional dyspepsia accompanied with emaciation and application of traditional Chinese medicine composition and preparation | |
| CN101757369A (en) | Medicine composition for treating acute goutry arthritis and preparation process thereof | |
| CN101422557A (en) | Medicine for treating colitis | |
| CN116139209A (en) | Composition for treating helicobacter pylori, coordinating intestines and stomach and increasing immunity | |
| CN1481891A (en) | Medication for chronic renal failure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060906 Termination date: 20100704 |